Abiopharma

🔍 SMOLYANSKY JULIE (Director)

Company: Lifeway Foods, Inc. (LWAY)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 2,000 shares of Common Stock, no par value at $25.26 per share (Direct)
  Date: 2026-08-19 | Code: P | equity_swap_involved: 0 | shares_owned_after: 2,214,095.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock, no par value (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 22,216.00 | Footnotes: F1
• Holds 0 shares of Common Stock, no par value (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 5,709.00 | Footnotes: F2
• Holds 0 shares of Common Stock, no par value (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 500,000.00 | Footnotes: F3
• Holds 6,070 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 6,068.00 | Footnotes: F4, F4, F4
• Holds 3,397 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 6,794.00 | Footnotes: F5, F5, F5
• Holds 486 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 484.00 | Footnotes: F6, F6, F6, F2
• Holds 340 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-19 | Code: H | shares_owned_after: 679.00 | Footnotes: F7, F7, F7, F2

Footnotes:

• F1: Held for the benefit of minor children.
• F2: Held by the Reporting Person's spouse.
• F3: Held by Smolyansky Holding LLC of which the reporting person is the beneficial owner of 50%. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
• F4: Each restricted stock unit has a value equal to one share of common stock. The remaining restricted stock units will vest on January 10, 2027, contingent on the Reporting Person's continued service on each applicable vesting date.
• F5: Each restricted stock unit has a value equal to one share of common stock. Of the remaining restricted stock units, 3,397 will vest on March 28, 2027 and 3,397 will vest on March 28, 2028, contingent on the Reporting Person's continued service on each applicable vesting date.
• F6: Each restricted stock unit has a value equal to one share of common stock. The remaining restricted stock units will vest on January 10, 2027, contingent on the Reporting Person's spouse's continued service on each applicable vesting date.
• F7: Each restricted stock unit has a value equal to one share of common stock. Of the remaining restricted stock units, 340 will vest on March 28, 2027 and 339 will vest on March 28, 2028, contingent on the Reporting Person's spouse's continued service on each applicable vesting date.